TegoScience Inc. (KOSDAQ:191420)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,120.00
-330.00 (-5.12%)
At close: Jul 20, 2026
Market Cap49.24B -67.2%
Revenue (ttm)5.83B -14.3%
Net Income-8.36B
EPS-1,044.73
Shares Out 8.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,557
Open6,450.00
Previous Close6,450.00
Day's Range5,890.00 - 6,640.00
52-Week Range5,890.00 - 19,370.00
Beta0.59
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 191420
Full Company Profile

Financial Performance

Financial Statements